Senesco Technologies, Inc. Share Price Nyse
Equities
US8172084084
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- USD | - |
|
Sales 2021 | - | Sales 2022 | - | Capitalization | 3.94M 312M |
---|---|---|---|---|---|
Net income 2021 | -66M -5.23B | Net income 2022 | -36M -2.85B | EV / Sales 2021 | - |
Net cash position 2021 | 25.09M 1.99B | Net Debt 2022 | 6.71M 531M | EV / Sales 2022 | - |
P/E ratio 2021 |
-0.74
x | P/E ratio 2022 |
-0.11
x | Employees | - |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 95.63% |
Latest transcript on Senesco Technologies, Inc.
Managers | Title | Age | Since |
---|---|---|---|
Sumit Aggarwal
CEO | Chief Executive Officer | - | 31/03/21 |
Daniel Geffken
DFI | Director of Finance/CFO | 67 | 31/10/20 |
Ali Hariri
CTO | Chief Tech/Sci/R&D Officer | - | 07/09/21 |
Members of the board | Title | Age | Since |
---|---|---|---|
Steven Rubin
BRD | Director/Board Member | 63 | 30/04/14 |
Alan Walts
BRD | Director/Board Member | 64 | 31/03/21 |
Sumit Aggarwal
CEO | Chief Executive Officer | - | 31/03/21 |
1st Jan change | Capi. | |
---|---|---|
+16.49% | 122B | |
+21.73% | 115B | |
+22.18% | 26.64B | |
-21.81% | 19.91B | |
-16.89% | 16.32B | |
-18.81% | 15.49B | |
-44.74% | 15.52B | |
+62.72% | 14.83B | |
+3.09% | 13.67B |